Notably, this study demonstrated that ALG3-mediated N-glycosylation of FOXD1 could enhance its nuclear localization, thereby promoting BNIP3-mediated mitophagy and reducing the sensitivity of NPC cells to gemcitabine. The gene discussed is FOXD1; the disease is nasopharyngeal carcinoma.